News

miRagen Therapeutics to Participate in Four Investor Conferences in November

miRagen Therapeutics, Inc. (NASDAQ:MGEN) a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that William S. Marshall, Ph.D., President and Chief Executive Officer, will provide a company overview at the following conferences in November.

  • Stifel 2017 Healthcare Conference
    • Presentation Date: Tuesday, November 14, 2017
    • Presentation Time: 8:45 a.m. ET
    • Location: Lotte New York Palace Hotel
  • Jefferies 2017 London Healthcare Conference
    • Presentation Date: Thursday, November 16, 2017
    • Presentation Time: 1:20 p.m. GMT
    • Location: Waldorf Hilton
  • 29th Annual Piper Jaffray Healthcare Conference
    • Presentation Date: Wednesday, November 29, 2017
    • Presentation Time: 9:30 a.m. ET
    • Location: Lotte New York Palace Hotel
  • Evercore ISI Biopharma Catalyst/Deep Dive Conference
    • Presentation Date: Thursday, November 30, 2017
    • Presentation Time: 8:20 a.m. ET
    • Location: Boston Harbor Hotel

The presentations will be webcast live and may be accessed by visiting the "Investors & Media" section of the Company’s web site at www.miragen.com. A replay of the webcasts will be available for 90 days.




Go Back